Efficacy and Safety of Immunomodulator as an Adjunct Therapy in New Pulmonary Tuberculosis(Category I) Patients.

This study has been completed.
Sponsor:
Information provided by (Responsible Party):
SK Sharma, All India Institute of Medical Sciences, New Delhi
ClinicalTrials.gov Identifier:
NCT00341328
First received: June 20, 2006
Last updated: April 25, 2013
Last verified: April 2013
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: March 2012
  Primary Completion Date: October 2011 (Final data collection date for primary outcome measure)